3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
NETWORK
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Gastrointestinal
1
Conditions
Uterine Cervical Dysplasia
14
Uterine Cervical Neoplasms
4
Vulvar Neoplasms
2
Squamous Intraepithelial Lesions
2
Precancerous Conditions
2
Papillomavirus Infections
2
HIV Infections
2
Vulvar High Grade Squamous Intraepithelial Lesion (HSIL)
1
Vaginal Neoplasms
1
Ovarian Neoplasms
1
Neoplasms
1
Neoplasm Metastasis
1
Fallopian Tube Neoplasms
1
Endometrial Neoplasms
1
Anus Neoplasms
1
Acquired Immunodeficiency Syndrome
1
Interventions
Fluorouracil
3
Watchful Waiting
2
Observation
2
Cisplatin
2
human papillomavirus vaccine, L1 type 16, 18
1
Transurethral Resection of Prostate
1
Radiotherapy
1
Proctoscopy
1
Papillomavirus Vaccines
1
Mass Screening
1
Light Coagulation
1
Laser Therapy
1
Isotretinoin
1
Interviews as Topic
1
Imiquimod
1
Human Papillomavirus Recombinant Vaccine nonavalent
1
Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
1
HIV Testing
1
Focus Groups
1
Data Collection
1
Colposcopy
1
Blood Specimen Collection
1
Acetic Acid
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Acquired Immunodeficiency Syndrome
×
Imiquimod
×
Gynecologic
×
Clear all
NCT02135419
2024-07-26
ANCHOR
AIDS Malignancy Consortium
Phase 3
Completed
4,446 enrolled
13 charts